Pharmaceutical manufacturing
Novarex Pharma develops, manufactures and supplies quality-assured medicines across cardiology, anti-infectives, gastroenterology and nutrition — from formulation through to the pharmacy shelf.
From molecule to pharmacy shelf
Feasibility, excipient screening and pilot batches in our development lab.
Process validation, ICH stability studies and analytical method transfer.
Controlled areas, in-process checks and a batch record for every run.
Quality unit sign-off, retained samples, then cold-chain-aware distribution.
What we do
Novarex works with distributors, hospitals, institutions and licence holders who need medicine that arrives on time and behaves the same way in every batch.
Tablets, capsules, dry powder suspensions, sachets, solutions and topicals produced on qualified lines.
View products →Generic development, fixed-dose combinations and taste-masked paediatric forms, from feasibility to scale-up.
Our R&D →Documented specifications, in-process controls and independent release by the quality unit.
How we test →Appointed distributor network, institutional supply and export documentation handled in-house.
Partner with us →Portfolio
A selection from the current catalogue. Each entry lists the generic name, dosage form and pack presentation.
Amlodipine besylate
A calcium channel blocker used in the management of hypertension and chronic stable angina. Manufactured on a dedicated…
Atorvastatin calcium
Lipid-lowering therapy for primary hypercholesterolaemia and cardiovascular risk reduction, supplied in blister packs with a 36-month shelf life.
Cefixime trihydrate
A third-generation oral cephalosporin presented as a taste-masked paediatric suspension, reconstituted with water at the point of dispensing.
Amoxicillin + clavulanic acid
Broad-spectrum beta-lactam therapy with a beta-lactamase inhibitor, produced in a segregated penicillin facility with dedicated air handling.
Esomeprazole magnesium
A proton pump inhibitor for reflux disease and ulcer healing, formulated with enteric-coated pellets for acid protection.
Domperidone maleate
A prokinetic agent for nausea, vomiting and functional dyspepsia, released against dissolution and content uniformity specifications.
Innovation
Every product is developed against a target profile, tested with validated methods, and held to stability data we generated ourselves. Nothing ships on assumption.
We define release profile, stability expectation and pack before a single trial batch is made.
HPLC and dissolution methods are developed and validated for specificity, accuracy and precision.
Long-term, intermediate and accelerated chambers run in parallel, with scheduled pull points.
Three consecutive validation batches confirm the process performs the same way every time.
News & events
Open to registered healthcare professionals, the session covers stewardship principles, resistance patterns and practical prescribing decisions.
Read more →We will be exhibiting alongside our distribution partners, with the formulation development team on hand to discuss contract manufacturing.
Read more →Our amlodipine besylate tablet has been granted registration, with commercial supply beginning next quarter through appointed distributors.
Read more →Q&A
A short version of what we are, who we supply and how to start a conversation.
Cannot find your answer? Ask the assistant in the corner of the screen, or write to us directly.
We develop, manufacture and supply finished pharmaceutical products — tablets, capsules, dry powder suspensions, sachets and topical preparations — across cardiology, anti-infectives, gastroenterology, pain management and nutrition. We also run contract manufacturing for other licence holders.
No. Novarex supplies licensed distributors, wholesalers, hospitals and institutions. Patients should obtain our medicines from a registered pharmacy on a valid prescription where one is required.
Our facility operates under current Good Manufacturing Practice. Every batch is released against documented specifications by a qualified person, with retained samples and full traceability from raw material to finished pack.
Yes. Send the molecule, strength, dosage form and expected annual volume through the contact form and our business development team will confirm feasibility, development timeline and indicative costing.
Commercial and partnership enquiries are answered within one working day. Product quality complaints and adverse event reports are acknowledged the same working day.
Send us your product list, market and volumes. Our business development team replies within one working day.
